8-KEarnings & ResultsExhibits & Filings

Merck & Co., Inc. 8-K Report, Financial Results (Jul 30, 2013)

Filed July 30, 2013For Securities:MRK

Summary

Merck & Co., Inc. (MRK) filed an 8-K on July 30, 2013, to report its financial results for the second quarter of 2013. The filing incorporates by reference a press release and supplemental information detailing the company's performance during the quarter. Investors should review these attached exhibits for specific financial figures, operational highlights, and forward-looking statements that were disclosed at the time. This report serves as a crucial update for shareholders, providing insights into Merck's revenue, earnings, and overall financial condition as of the end of the second quarter. While the 8-K itself does not contain the detailed financial tables, it directs investors to the readily available press release and supplemental data, which are essential for a comprehensive understanding of the company's recent performance and strategic positioning.

Key Highlights

  • 1Merck filed an 8-K on July 30, 2013, reporting its second quarter 2013 financial results.
  • 2The filing incorporates by reference a press release dated July 30, 2013 (Exhibit 99.1).
  • 3Supplemental financial information not included in the press release is also attached as Exhibit 99.2.
  • 4The 8-K indicates the information is furnished under Item 2.02 (Results of Operations and Financial Condition).
  • 5This report provides an official update on Merck's financial performance for the second quarter of 2013.
  • 6The information provided is not deemed 'filed' for purposes of Section 18 of the Exchange Act, but is incorporated by reference in future filings as specified.

Frequently Asked Questions

The main purpose of this 8-K filing is to report Merck & Co., Inc.'s financial results and condition for the second quarter of 2013. It officially announces the company's performance during that period.

The detailed financial results are not directly in the 8-K form itself. The filing incorporates by reference a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) issued by Merck on July 30, 2013, which contain the specific financial figures and details for the second quarter.

This specific 8-K filing primarily focuses on the financial results for the second quarter of 2013. While financial reports can sometimes allude to strategic impacts, any major new business developments or strategic announcements would typically be detailed in separate 8-K filings or other corporate communications.

The filing states that the information furnished under Item 2.02 shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, unless expressly incorporated by reference into a specific filing.